Your browser doesn't support javascript.
loading
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.
Enjeti, Anoop K; Agarwal, Rishu; Blombery, Piers; Chee, Lynette; Chua, Chong Chyn; Grigg, Andrew; Hamad, Nada; Iland, Harry; Lane, Steven; Perkins, Andrew; Singhal, Deepak; Tate, Courtney; Tiong, Ing Soo; Ross, David M.
Afiliación
  • Enjeti AK; Australasian Leukaemia and Lymphoma Group, Australia; Department of Haematology, Calvary Mater Hospital, Waratah, NSW, Australia; New South Wales Health Pathology, John Hunter Hospital New Lambton Heights, NSW, Australia; University of Newcastle, Callaghan, NSW, Australia. Electronic address: Anoop.
  • Agarwal R; Australasian Leukaemia and Lymphoma Group, Australia; Austin Pathology, Melbourne, Vic, Australia.
  • Blombery P; Australasian Leukaemia and Lymphoma Group, Australia; Department of Clinical Haematology, The Royal Melbourne Hospital, Vic, Australia; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Department of Medicine, The University of Melbourne, Parkville, Vic, Australia.
  • Chee L; Australasian Leukaemia and Lymphoma Group, Australia; Department of Clinical Haematology, The Royal Melbourne Hospital, Vic, Australia; Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Department of Medicine, The University of Melbourne, Parkville, Vic, Australia.
  • Chua CC; Australasian Leukaemia and Lymphoma Group, Australia; Department of Clinical Haematology, Northern Hospital, Melbourne, Vic, Australia.
  • Grigg A; Australasian Leukaemia and Lymphoma Group, Australia; Department Clinical Haematology, Austin Hospital Melbourne, Vic, Australia.
  • Hamad N; Australasian Leukaemia and Lymphoma Group, Australia; Department of Haematology, St Vincent's Hospital School of Medicine, University of Notre Dame, NSW, Australia; St Vincent's Clinical School Sydney, University of New South Wales, NSW, Australia.
  • Iland H; Australasian Leukaemia and Lymphoma Group, Australia; Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Lane S; Australasian Leukaemia and Lymphoma Group, Australia; Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia; Cancer Program, QIMR Berghofer Medical Research Institute Brisbane, Qld, Australia.
  • Perkins A; Australasian Leukaemia and Lymphoma Group, Australia; Head of Genomic Medicine, Alfred Health, Melbourne, Vic, Australia.
  • Singhal D; Australasian Leukaemia and Lymphoma Group, Australia; Haematology Directorate, SA Pathology and Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Tate C; Australasian Leukaemia and Lymphoma Group, Australia; Department of Clinical Haematology, Princess Alexandra Hospital, Queensland Health, Brisbane, Qld, Australia; University of Queensland, Qld, Australia.
  • Tiong IS; Australasian Leukaemia and Lymphoma Group, Australia; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia; Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Vic, Australia; Monash University, Melbourne, Vic, Australia.
  • Ross DM; Australasian Leukaemia and Lymphoma Group, Australia; Haematology Directorate, SA Pathology and Royal Adelaide Hospital, Adelaide, SA, Australia; Department of Haematology, Flinders University and Medical Centre, Adelaide, SA, Australia.
Pathology ; 54(4): 389-398, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35461716

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia / Enfermedades Mielodisplásicas-Mieloproliferativas / Linfoma / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pathology Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia / Enfermedades Mielodisplásicas-Mieloproliferativas / Linfoma / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pathology Año: 2022 Tipo del documento: Article